Time-Varying Kinetic Modeling for Single-Tracer PET Blood Flow Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PET imaging methods require multiple radiotracers and lengthy imaging processes to measure blood flow and glucose metabolism, which are resource-intensive and costly, and are limited by the need for flow-specific tracers and high radiation exposure.
Innovation Solution
The method employs high temporal-resolution dynamic PET imaging using a single radiotracer, such as 18F-FDG, with a time-varying kinetic model to quantify blood flow without the need for a flow-specific tracer, allowing for multiparametric imaging by leveraging early-dynamic PET data to estimate blood flow and glucose metabolism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple radiotracers are used to measure blood flow and glucose metabolism, then measurement precision is improved, but device complexity and imaging time increase
Solution Approach 1:
The patent applies universality by enabling a single radiotracer (18F-FDG) to serve multiple functions: measuring both glucose metabolism and blood flow. The time-varying kinetic model allows the same tracer data to be used for quantifying multiple physiological parameters, eliminating the need for separate flow-specific tracers like 15O-water or 82Rb-chloride.
Solution Approach 2:
The patent merges the measurement of blood flow and glucose metabolism into a single imaging process. By combining the kinetic modeling of tracer uptake with blood flow quantification, the system integrates multiple parameters that would traditionally require separate scans into one unified measurement approach.
2Measurement precision
If multiple radiotracers are used to measure blood flow and glucose metabolism, then measurement precision is improved, but imaging time and cost increase
Solution Approach 1:
The patent applies universality by enabling a single radiotracer (18F-FDG) to serve multiple functions: measuring both glucose metabolism and blood flow. The time-varying kinetic model allows the same tracer data to be used for quantifying multiple physiological parameters, eliminating the need for separate flow-specific tracers like 15O-water or 82Rb-chloride.
Solution Approach 2:
The patent uses preliminary action by analyzing early-dynamic PET data (acquired within the first few minutes after tracer injection) to quantify blood flow before the tracer reaches steady-state metabolic conditions. This allows blood flow measurement to be obtained from the initial phase of tracer uptake, eliminating the need for separate delayed flow imaging scans.
3Measurement precision
If flow-specific radiotracers are used, then measurement precision for blood flow is improved, but radiation exposure and cost increase
Solution Approach 1:
The patent applies universality by enabling a single radiotracer (18F-FDG) to serve multiple functions: measuring both glucose metabolism and blood flow. The time-varying kinetic model allows the same tracer data to be used for quantifying multiple physiological parameters, eliminating the need for separate flow-specific tracers like 15O-water or 82Rb-chloride.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces imaging time, cost, and radiation exposure, enabling accurate multiparametric imaging of blood flow and metabolism with improved clinical accessibility and applicability to various diseases, including cancer and heart diseases, by using a single-tracer injection.
Implementation Method 1
Positron emission tomography (PET) imaging is a method of imaging molecular processes in the body. A radioactive tracer is administered to a subject. The subject is placed into a PET scanner for image acquisition.
Data Source
AI summary
Systems and methods are disclosed for quantifying blood flow using time-varying kinetic modeling of high temporal-resolution dynamic positron emission tomography (PET) data. A single tracer is introduced into the body. A first set of images is acquired, via PET, of at least a portion of the body at a plurality of predetermined time intervals. Based on the first set of images, an intensity of the tracer in the at least the portion of the body is determined as a function of time. The intensity of the tracer as a function of time is modeled using a time-varying kinetic model. Based on the model, the blood flow through the at least the portion of the body is quantified. Additional images may be acquired and used to quantify additional parameter(s), such as glucose metabolism, amyloid load, etc., with the single tracer.